CXCL4 Deficiency and Lung Injury in Neonates
Author Information
Author(s): Yu Bingrui, Jia Siyuan, Chen Yu, Guan Rong, Chen Shuyu, Tang Wanwen, Bao Tianping, Tian Zhaofang
Primary Institution: The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University
Hypothesis
This study aimed to elucidate the involvement of CXCL4 in hyperoxia-induced neonatal lung injury and fibrosis, with a particular focus on its influence on M4 macrophages.
Conclusion
CXCL4 contributes to hyperoxia-induced lung injury and fibrosis through modulation of cytokine release, alveolar cell proliferation, lipid metabolism, and the regulation of macrophage phenotype and function.
Supporting Evidence
- Elevated CXCL4 levels and M4 macrophage activation were identified in the lung tissue of BPD model mice.
- CXCL4 deficiency conferred protection to alveolar type 2 epithelial cells and mitigated pulmonary fibrosis.
- In vitro, CXCL4 promoted M4 macrophage differentiation and increased macrophage migration.
Takeaway
This study found that a lack of CXCL4 helps protect baby mice from lung damage caused by too much oxygen, which is important for understanding and treating lung problems in premature infants.
Methodology
A BPD model in neonatal mice was established through continuous exposure to 95% O2 for 7 days, comparing lung damage and regeneration between wild-type and CXCL4 knockout mice.
Potential Biases
The study did not assess potential biases related to the use of only male mice.
Limitations
The expression of CXCL4 in human samples was not assessed, clinical symptoms and the impact of CXCL4 on lung function in BPD mice were not investigated, and only male mice were used.
Participant Demographics
Neonatal mice (within 24 hours of birth) were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website